FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2
- PMID: 16965535
- DOI: 10.1111/j.1742-4658.2006.05468.x
FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2
Abstract
FOXM1c transactivates the c-myc promoter via the P1 and P2 TATA boxes using a new mechanism. Whereas the P1 TATA box TATAATGC requires its sequence context to be FOXM1c responsive, the P2 TATA box TATAAAAG alone is sufficient to confer FOXM1c responsiveness to any minimal promoter. FOXM1c transactivates by binding to the TATA box as well as directly to TATA-binding protein, transcription factor IIB and transcription factor IIA. This new transactivation mechanism is clearly distinguished from the function of FOXM1c as a conventional transcription factor. The central domain of FOXM1c functions as an essential domain for activation via the TATA box, but as an inhibitory domain (retinoblastoma protein-independent transrepression domain and retinoblastoma protein-recruiting negative regulatory domain) for transactivation via conventional FOXM1c-binding sites. Each promoter with the P2 TATA box TATAAAAG is postulated to be transactivated by FOXM1c. This was demonstrated for the promoters of c-fos, hsp70 and histone H2B/a. A database search revealed almost 300 probable FOXM1c target genes, many of which function in proliferation and tumorigenesis. Accordingly, dominant-negative FOXM1c proteins reduced cell growth approximately threefold, demonstrating a proliferation-stimulating function for wild-type FOXM1c.
Similar articles
-
FOXM1c and Sp1 transactivate the P1 and P2 promoters of human c-myc synergistically.Biochem Biophys Res Commun. 2007 Jan 5;352(1):61-8. doi: 10.1016/j.bbrc.2006.10.151. Epub 2006 Nov 3. Biochem Biophys Res Commun. 2007. PMID: 17141659
-
The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site.Biol Chem. 2007 Aug;388(8):805-18. doi: 10.1515/BC.2007.094. Biol Chem. 2007. PMID: 17655499
-
Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1.Biochem Biophys Res Commun. 2008 Mar 28;368(1):107-15. doi: 10.1016/j.bbrc.2008.01.039. Epub 2008 Jan 17. Biochem Biophys Res Commun. 2008. PMID: 18206647
-
FOXM1, a typical proliferation-associated transcription factor.Biol Chem. 2007 Dec;388(12):1257-74. doi: 10.1515/BC.2007.159. Biol Chem. 2007. PMID: 18020943 Review.
-
TBP homologues in embryo transcription: who does what?EMBO Rep. 2007 Nov;8(11):1016-8. doi: 10.1038/sj.embor.7401093. EMBO Rep. 2007. PMID: 17972900 Free PMC article. Review. No abstract available.
Cited by
-
DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.J Biol Chem. 2009 Jul 31;284(31):20593-601. doi: 10.1074/jbc.M109.021477. Epub 2009 Jun 4. J Biol Chem. 2009. PMID: 19497851 Free PMC article.
-
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.Oncogene. 2021 Jul;40(30):4847-4858. doi: 10.1038/s41388-021-01895-2. Epub 2021 Jun 21. Oncogene. 2021. PMID: 34155349
-
Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer.Breast Cancer Res. 2023 Jun 27;25(1):76. doi: 10.1186/s13058-023-01675-8. Breast Cancer Res. 2023. PMID: 37370117 Free PMC article. Review.
-
FOX(M1) news--it is cancer.Mol Cancer Ther. 2013 Mar;12(3):245-54. doi: 10.1158/1535-7163.MCT-12-0712. Epub 2013 Feb 26. Mol Cancer Ther. 2013. PMID: 23443798 Free PMC article. Review.
-
FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation.Cell Death Dis. 2021 May 25;12(6):542. doi: 10.1038/s41419-021-03822-5. Cell Death Dis. 2021. PMID: 34035233 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous